AFJK logo

AIMEI HEALTH TECHNOLOGY CO

AFJKNASDAQ
🏆 #4561 by market capUS Equity
$12.04▼ $0.25 (−2.11%)
Market closed · at close
🔔
Track AFJK
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 2.1%
7d▼ 5.2%
14d▼ 5.2%
30d▼ 5.2%
ytd▼ 81.8%
1y▲ 8.0%
🏦Market Cap
$38M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
72
Fair

Trading Snapshot

Day Range
$11.90 – $12.25
52-Week Range
$6.75 – $130.37
Volume
$2.48B
Avg Volume
$2.89B
Shares Outstanding
3.2M
Next Earnings
Nov 11, 2026

Fundamentals Snapshot

Annual Revenue
$7M
Last Q Revenue
$2M
P/E Ratio
176.5
P/S Ratio
0.0x
EPS (TTM)
$0.40
Dividend Yield
0.00%
Dilution (1yr)
−55.2%

Why Investors Own AFJK

  • ✓High-growth profile — revenue up +10.0% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 58% gross margin and 5% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

AFJK logo

AIMEI HEALTH TECHNOLOGY CO

AFJK
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$836K▼ −21.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$565K▼ −15.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
4.0M▼ −55.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$2M▼ −$2M YoY
StockOtter · stockotter.space

About AIMEI HEALTH TECHNOLOGY CO

Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
72/100

Analyst Price Target

ⓘ
Average Target
$12.30
▲ +2.2% Upside
High Target$14.33
Low Target$10.71
Based on 31 analysts

Latest News & Updates

Defense World·Aug 12

Aimei Health Technology (NASDAQ:AFJK) Shares Up 0.4% – Here’s What Happened

Aimei Health Technology Co., Ltd. (NASDAQ: AFJK - Get Free Report)'s share price rose 0.4% during trading on Tuesday. The company traded as high as $12.14 and last traded at $12.01. Approximately 84,299 shares were trade

Globe News Wire·Jul 8

AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.

Aimei Health Technology Co. , Ltd. Announces Termination of Business Combination Agreement NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co. , Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the "Company") announc